LPL Financial’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.35K | Sell |
33,809
-200
| -0.6% | -$80 | ﹤0.01% | 5932 |
|
|
2025
Q4 | $14.3K | Sell |
34,009
-1,090
| -3% | -$578 | ﹤0.01% | 5832 |
|
|
2025
Q3 | $23.6K | Hold |
35,099
| – | – | ﹤0.01% | 5726 |
|
|
2025
Q2 | $19K | Buy |
35,099
+7,670
| +28% | +$4.55K | ﹤0.01% | 5477 |
|
|
2025
Q1 | $18K | Sell |
27,429
-3,602
| -12% | -$3.81K | ﹤0.01% | 5269 |
|
|
2024
Q4 | $31.7K | Buy |
31,031
+16,498
| +114% | +$30.2K | ﹤0.01% | 5153 |
|
|
2024
Q3 | $12.6K | Hold |
14,533
| – | – | ﹤0.01% | 5114 |
|
|
2024
Q2 | $5.21K | Buy |
14,533
+3,199
| +28% | +$1.73K | ﹤0.01% | 4996 |
|
|
2024
Q1 | $7.6K | Buy |
+11,334
| New | +$8.22K | ﹤0.01% | 4894 |
|
|
2022
Q4 | – | Sell |
-10,671
| Closed | -$52K | – | 4540 |
|
|
2022
Q3 | $52K | Buy |
+10,671
| New | +$54.8K | ﹤0.01% | 4227 |
|
|
2022
Q1 | – | Sell |
-11,498
| Closed | -$86K | – | 4367 |
|
|
2021
Q4 | $86K | Sell |
11,498
-1,395
| -11% | -$12.1K | ﹤0.01% | 4161 |
|
|
2021
Q3 | $116K | Sell |
12,893
-2,132
| -14% | -$21.1K | ﹤0.01% | 4107 |
|
|
2021
Q2 | $180K | Buy |
15,025
+2,957
| +25% | +$33.5K | ﹤0.01% | 3933 |
|
|
2021
Q1 | $151K | Sell |
12,068
-8,147
| -40% | -$110K | ﹤0.01% | 3846 |
|
|
2020
Q4 | $315K | Sell |
20,215
-2,190
| -10% | -$25.7K | ﹤0.01% | 3158 |
|
|
2020
Q3 | $212K | Buy |
22,405
+8,499
| +61% | +$91.9K | ﹤0.01% | 3160 |
|
|
2020
Q2 | $125K | Buy |
13,906
+1,900
| +16% | +$17.6K | ﹤0.01% | 3257 |
|
|
2020
Q1 | $76K | Buy |
12,006
+1,031
| +9% | +$7.65K | ﹤0.01% | 3036 |
|
|
2019
Q4 | $92K | Sell |
10,975
-4,650
| -30% | -$42.8K | ﹤0.01% | 3229 |
|
|
2019
Q3 | $141K | Buy |
15,625
+3,200
| +26% | +$35.9K | ﹤0.01% | 3102 |
|
|
2019
Q2 | $134K | Sell |
12,425
-700
| -5% | -$7.45K | ﹤0.01% | 3120 |
|
|
2019
Q1 | $125K | Sell |
13,125
-3,315
| -20% | -$33.9K | ﹤0.01% | 3041 |
|
|
2018
Q4 | $189K | Buy |
16,440
+840
| +5% | +$10.4K | ﹤0.01% | 2826 |
|
|
2018
Q3 | $264K | Buy |
15,600
+4,800
| +44% | +$73K | ﹤0.01% | 2793 |
|
|
2018
Q2 | $153K | Buy |
+10,800
| New | +$179K | ﹤0.01% | 3045 |
|
|
2015
Q4 | – | Sell |
-32,835
| Closed | -$200K | – | 3235 |
|
|
2015
Q3 | $200K | Buy |
32,835
+1,150
| +4% | +$9.48K | ﹤0.01% | 2513 |
|
|
2015
Q2 | $318K | Buy |
+31,685
| New | +$409K | ﹤0.01% | 2258 |
|
|
2014
Q2 | – | Sell |
-10,461
| Closed | -$189K | – | 2739 |
|
|
2014
Q1 | $189K | Buy |
+10,461
| New | +$202K | ﹤0.01% | 2462 |
|
Other funds holding SGMO
AC
VCM
VFT
LPL Financial's SGMO Position: Q1 2026 in Review
LPL Financial reduced its SANGAMO THERAPEUTICS INC (SGMO) stake by 0.59% in Q1 2026, selling an estimated $80 and leaving 33,809 shares worth $8.35K. The position accounts for ﹤0.01% of the portfolio, ranked #5932.
LPL Financial first reported a position in SGMO in Q1 2014 and has held it in 28 quarters since. The position peaked at $318K in Q2 2015. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.
- LPL Financial held 33,809 shares of SANGAMO THERAPEUTICS INC worth $8.35K as of Q1 2026.
- LPL Financial sold 200 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $80.
- SANGAMO THERAPEUTICS INC made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5932 holding.
- LPL Financial first reported a position in SANGAMO THERAPEUTICS INC in Q1 2014 and has held it in 28 quarters since.
- LPL Financial's SANGAMO THERAPEUTICS INC position peaked at $318K in Q2 2015.
- 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.
Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.